血管紧张素Ⅰ转化酶:修订间差异
删除的内容 添加的内容
→同义词: 內容擴充 |
|||
第36行: | 第36行: | ||
* CD143 |
* CD143 |
||
* ACE1 |
* ACE1 |
||
==延伸閲讀== |
|||
{{refbegin | 2}} |
|||
{{PBB_Further_reading |
|||
| citations = |
|||
*{{cite journal | author=Niu T, Chen X, Xu X |title=Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications |journal=Drugs |volume=62 |issue= 7 |pages= 977–93 |year= 2002 |pmid= 11985486| doi=10.2165/00003495-200262070-00001}} |
|||
*{{cite journal | author=Roĭtberg GE, Tikhonravov AV, Dorosh ZhV |title=[Role of angiotensin-converting enzyme gene polymorphism in the development of metabolic syndrome] |journal=Ter. Arkh. |volume=75 |issue= 12 |pages= 72–7 |year= 2004 |pmid= 14959477 |doi= }} |
|||
*{{cite journal | author=Vynohradova SV |title=[The role of angiotensin-converting enzyme gene I/D polymorphism in development of metabolic disorders in patients with cardiovascular pathology] |journal=Tsitol. Genet. |volume=39 |issue= 1 |pages= 63–70 |year= 2005 |pmid= 16018179 |doi= }} |
|||
*{{cite journal | author=König S, Luger TA, Scholzen TE |title=Monitoring neuropeptide-specific proteases: processing of the proopiomelanocortin peptides adrenocorticotropin and alpha-melanocyte-stimulating hormone in the skin |journal=Exp. Dermatol. |volume=15 |issue= 10 |pages= 751–61 |year= 2006 |pmid= 16984256 |doi= 10.1111/j.1600-0625.2006.00472.x }} |
|||
*{{cite journal | author=Sabbagh AS |author-separator=, |author2= Otrock ZK |author3= Mahfoud ZR |author4=and others |title=Angiotensin-converting enzyme gene polymorphism and allele frequencies in the Lebanese population: prevalence and review of the literature |journal=Mol. Biol. Rep. |volume=34 |issue= 1 |pages= 47–52 |year= 2007 |pmid= 17103020 |doi= 10.1007/s11033-006-9013-y |displayauthors=3 }} |
|||
*{{cite journal | author=Castellon R, Hamdi HK |title=Demystifying the ACE polymorphism: from genetics to biology |journal=Curr. Pharm. Des. |volume=13 |issue= 12 |pages= 1191–8 |year= 2007 |pmid= 17504229| doi=10.2174/138161207780618902}} |
|||
*{{cite journal | author=Lazartigues E, Feng Y, Lavoie JL |title=The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases |journal=Curr. Pharm. Des. |volume=13 |issue= 12 |pages= 1231–45 |year= 2007 |pmid= 17504232| doi=10.2174/138161207780618911}} |
|||
}} |
|||
{{refend}} |
|||
==外部鏈接== |
|||
* {{MeshName|Angiotensin+Converting+Enzyme}} |
|||
{{蛋白酶类}} |
{{蛋白酶类}} |
||
[[Category:EC 3.4.15]] |
[[Category:EC 3.4.15]] |
||
[[Category:激肽系统]] |
[[Category:激肽系统]] |
2014年5月25日 (日) 06:21的版本
血管紧张肽I转化酶 | |||||||
---|---|---|---|---|---|---|---|
| |||||||
识别码 | |||||||
EC編號 | 3.4.15.1 | ||||||
CAS号 | 9015-82-1 | ||||||
数据库 | |||||||
IntEnz | IntEnz浏览 | ||||||
BRENDA | BRENDA入口 | ||||||
ExPASy | NiceZyme浏览 | ||||||
KEGG | KEGG入口 | ||||||
MetaCyc | 代谢路径 | ||||||
PRIAM | 概述 | ||||||
PDB | RCSB PDB PDBj PDBe PDBsum | ||||||
|
血管紧张肽I转化酶(英語:Angiotensin-converting enzyme,又称为血管紧张素转化酶,简称为ACE,EC 3.4.15.1)是一种外肽酶。
功能
主要功能有以下两个:
血管紧张素转化酶因这两种功能而成为治疗高血压、心力衰竭、2型糖尿病和糖尿病肾病等疾病的理想靶点。血管紧张素转化酶抑制剂能减少血管紧张素II的生成,并增加缓激肽的活性。
此外,ACE也能催化血管紧张素-(1-9)转化为血管紧张素-(1-7)。
参见
同义词
血管紧张素转化酶(ACE)也被称作:
- 肽基二肽酶A (peptidyl dipeptidase A)
- 羧基组织蛋白酶(carboxycathepsin)
- 激肽酶II (kininase II)
- CD143
- ACE1
延伸閲讀
- Niu T, Chen X, Xu X. Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications. Drugs. 2002, 62 (7): 977–93. PMID 11985486. doi:10.2165/00003495-200262070-00001.
- Roĭtberg GE, Tikhonravov AV, Dorosh ZhV. [Role of angiotensin-converting enzyme gene polymorphism in the development of metabolic syndrome]. Ter. Arkh. 2004, 75 (12): 72–7. PMID 14959477.
- Vynohradova SV. [The role of angiotensin-converting enzyme gene I/D polymorphism in development of metabolic disorders in patients with cardiovascular pathology]. Tsitol. Genet. 2005, 39 (1): 63–70. PMID 16018179.
- König S, Luger TA, Scholzen TE. Monitoring neuropeptide-specific proteases: processing of the proopiomelanocortin peptides adrenocorticotropin and alpha-melanocyte-stimulating hormone in the skin. Exp. Dermatol. 2006, 15 (10): 751–61. PMID 16984256. doi:10.1111/j.1600-0625.2006.00472.x.
- Sabbagh AS; Otrock ZK; Mahfoud ZR; et al. Angiotensin-converting enzyme gene polymorphism and allele frequencies in the Lebanese population: prevalence and review of the literature. Mol. Biol. Rep. 2007, 34 (1): 47–52. PMID 17103020. doi:10.1007/s11033-006-9013-y. 已忽略未知参数
|author-separator=
(帮助) - Castellon R, Hamdi HK. Demystifying the ACE polymorphism: from genetics to biology. Curr. Pharm. Des. 2007, 13 (12): 1191–8. PMID 17504229. doi:10.2174/138161207780618902.
- Lazartigues E, Feng Y, Lavoie JL. The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases. Curr. Pharm. Des. 2007, 13 (12): 1231–45. PMID 17504232. doi:10.2174/138161207780618911.
外部鏈接
|